Top

European Journal of Medical Research

Published in:

Open Access 01-12-2023 | Cervical Cancer | Review

Research progress of metabolomics in cervical cancer

Authors: Yuhan Jia, Kun Zou, Lijuan Zou

Published in: European Journal of Medical Research | Issue 1/2023

Abstract

Introduction

Cervical cancer threatens women's health seriously. In recent years, the incidence of cervical cancer is on the rise, and the age of onset tends to be younger. Prevention, early diagnosis and specific treatment have become the main means to change the prognosis of cervical cancer patients. Metabolomics research can directly reflect the changes of biochemical processes and microenvironment in the body, which can provide a comprehensive understanding of the changes of metabolites in the process of disease occurrence and development, and provide new ways for the prevention and diagnosis of diseases.

Objectives

The aim of this study is to review the metabolic changes in cervical cancer and the application of metabolomics in the diagnosis and treatment.

Methods

PubMed, Web of Science, Embase and Scopus electronic databases were systematically searched for relevant studies published up to 2022.

Results

With the emergence of metabolomics, metabolic regulation and cancer research are further becoming a focus of attention. By directly reflecting the changes in the microenvironment of the body, metabolomics research can provide a comprehensive understanding of the patterns of metabolites in the occurrence and development of diseases, thus providing new ideas for disease prevention and diagnosis.

Conclusion

With the continuous, in-depth research on metabolomics research technology, it will bring more benefits in the screening, diagnosis and treatment of cervical cancer with its advantages of holistic and dynamic nature.

Small W Jr, Bacon MA, Bajaj A, Chuang LT, Fisher BJ, Harkenrider MM, et al. Cervical cancer: a global health crisis. Cancer. 2017;123(13):2404–12. https://doi.org/10.1002/cncr.30667.CrossRefPubMed

Castellsagué X, Díaz M, de Sanjosé S, Muñoz N, Herrero R, Franceschi S, et al. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. J Natl Cancer Inst. 2006;98(5):303–15. https://doi.org/10.1093/jnci/djj067.CrossRefPubMed

Popalis ML, Ramirez SI, Leach KM, Granzow ME, Stoltzfus KC, Moss JL. Improving cervical cancer screening rates: a scoping review of resources and interventions. Cancer Causes Control CCC. 2022;33(11):1325–33. https://doi.org/10.1007/s10552-022-01618-2.CrossRefPubMedPubMedCentral

Salehiniya H, Momenimovahed Z, Allahqoli L, Momenimovahed S, Alkatout I. Factors related to cervical cancer screening among Asian women. Eur Rev Med Pharmacol Sci. 2021;25(19):6109–22. https://doi.org/10.26355/eurrev_202110_26889.CrossRefPubMed

Nicholson JK, Lindon JC, Holmes E. “Metabonomics”: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica Fate Foreign Compounds Biol Syst. 1999;29(11):1181–9. https://doi.org/10.1080/004982599238047.CrossRef

Chouchani ET, Pell VR, Gaude E, Aksentijević D, Sundier SY, Robb EL, et al. Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS. Nature. 2014;515(7527):431–5. https://doi.org/10.1038/nature13909.CrossRefPubMedPubMedCentral

Manchester M, Anand A. Metabolomics: strategies to define the role of metabolism in virus infection and pathogenesis. Adv Virus Res. 2017;98:57–81. https://doi.org/10.1016/bs.aivir.2017.02.001.CrossRefPubMed

Yang K, Xia B, Wang W, Cheng J, Yin M, Xie H, et al. A Comprehensive analysis of metabolomics and transcriptomics in cervical cancer. Sci Rep. 2017;7:43353. https://doi.org/10.1038/srep43353.CrossRefPubMedPubMedCentral

Morandi A, Taddei ML, Chiarugi P, Giannoni E. Targeting the metabolic reprogramming that controls epithelial-to-mesenchymal transition in aggressive tumors. Front Oncol. 2017;7:40. https://doi.org/10.3389/fonc.2017.00040.CrossRefPubMedPubMedCentral

10.

Nam M, Seo SS, Jung S, Jang SY, Lee J, Kwon M, et al. Comparable plasma lipid changes in patients with high-grade cervical intraepithelial neoplasia and patients with cervical cancer. J Proteome Res. 2021;20(1):740–50. https://doi.org/10.1021/acs.jproteome.0c00640.CrossRefPubMed

11.

Walker-Samuel S, Ramasawmy R, Torrealdea F, Rega M, Rajkumar V, Johnson SP, et al. In vivo imaging of glucose uptake and metabolism in tumors. Nat Med. 2013;19(8):1067–72. https://doi.org/10.1038/nm.3252.CrossRefPubMedPubMedCentral

12.

Sitter B, Bathen T, Hagen B, Arentz C, Skjeldestad FE, Gribbestad IS. Cervical cancer tissue characterized by high-resolution magic angle spinning MR spectroscopy. MAGMA. 2004;16(4):174–81. https://doi.org/10.1007/s10334-003-0025-5.CrossRefPubMed

13.

Zhan YS, Feng L, Tang SH, Li WG, Xu M, Liu TF, et al. Glucose metabolism disorders in cancer patients in a Chinese population. Medical Oncol. 2010;27(2):177–84. https://doi.org/10.1007/s12032-009-9189-9.CrossRef

14.

Courtnay R, Ngo DC, Malik N, Ververis K, Tortorella SM, Karagiannis TC. Cancer metabolism and the Warburg effect: the role of HIF-1 and PI3K. Mol Biol Rep. 2015;42(4):841–51. https://doi.org/10.1007/s11033-015-3858-x.CrossRefPubMed

15.

Wang JX, Choi SYC, Niu X, Kang N, Xue H, Killam J, et al. Lactic acid and an acidic tumor microenvironment suppress anticancer immunity. Int J Mol Sci. 2020. https://doi.org/10.3390/ijms21218363.CrossRefPubMedPubMedCentral

16.

Kim MH, Green SD, Lin CC, Konig H. Engineering tools for regulating hypoxia in tumour models. J Cell Mol Med. 2021;25(16):7581–92. https://doi.org/10.1111/jcmm.16759.CrossRefPubMedPubMedCentral

17.

Lyng H, Sitter B, Bathen TF, Jensen LR, Sundfør K, Kristensen GB, et al. Metabolic mapping by use of high-resolution magic angle spinning 1H MR spectroscopy for assessment of apoptosis in cervical carcinomas. BMC Cancer. 2007;7:11. https://doi.org/10.1186/1471-2407-7-11.CrossRefPubMedPubMedCentral

18.

Stepka P, Vsiansky V, Raudenska M, Gumulec J, Adam V, Masarik M. Metabolic and amino acid alterations of the tumor microenvironment. Curr Med Chem. 2021;28(7):1270–89. https://doi.org/10.2174/0929867327666200207114658.CrossRefPubMed

19.

Mamtimin B, Upur H, Kong B, Eli M, Turahun A. Plasma amino acid profiling of “same symptom for different disease” in Uyghur medicine based on high-performance liquid chromatography. J Central South University Med Sci. 2014;39(6):558–63. https://doi.org/10.11817/j.issn.1672-7347.2014.06.003.CrossRef

20.

Adeva-Andany M, López-Ojén M, Funcasta-Calderón R, Ameneiros-Rodríguez E, Donapetry-García C, Vila-Altesor M, et al. Comprehensive review on lactate metabolism in human health. Mitochondrion. 2014;17:76–100. https://doi.org/10.1016/j.mito.2014.05.007.CrossRefPubMed

21.

Gray LR, Tompkins SC, Taylor EB. Regulation of pyruvate metabolism and human disease. Cell Mol Life Sci CMLS. 2014;71(14):2577–604. https://doi.org/10.1007/s00018-013-1539-2.CrossRefPubMed

22.

Qi Q, Ling Y, Zhu M, Zhou L, Wan M, Bao Y, et al. Promoter region methylation and loss of protein expression of PTEN and significance in cervical cancer. Biomedical reports. 2014;2(5):653–8. https://doi.org/10.3892/br.2014.298.CrossRefPubMedPubMedCentral

23.

Taddei ML, Pardella E, Pranzini E, Raugei G, Paoli P. Role of tyrosine phosphorylation in modulating cancer cell metabolism. Biochim Biophys Acta. 2020;1874(2):188442. https://doi.org/10.1016/j.bbcan.2020.188442.CrossRef

24.

Chan EC, Koh PK, Mal M, Cheah PY, Eu KW, Backshall A, et al. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS). J Proteome Res. 2009;8(1):352–61. https://doi.org/10.1021/pr8006232.CrossRefPubMed

25.

Wang H, Zhang H, Deng P, Liu C, Li D, Jie H, et al. Tissue metabolic profiling of human gastric cancer assessed by (1)H NMR. BMC Cancer. 2016;16:371. https://doi.org/10.1186/s12885-016-2356-4.CrossRefPubMedPubMedCentral

26.

Hasim A, Aili A, Maimaiti A, Mamtimin B, Abudula A, Upur H. Plasma-free amino acid profiling of cervical cancer and cervical intraepithelial neoplasia patients and its application for early detection. Mol Biol Rep. 2013;40(10):5853–9. https://doi.org/10.1007/s11033-013-2691-3.CrossRefPubMed

27.

Tapiero H, Mathé G, Couvreur P, Tew KD II. Glutamine and glutamate. Biomed Pharmacother. 2002;56(9):446–57. https://doi.org/10.1016/s0753-3322(02)00285-8.CrossRefPubMed

28.

Cluntun AA, Lukey MJ, Cerione RA, Locasale JW. Glutamine metabolism in cancer: understanding the heterogeneity. Trends Cancer. 2017;3(3):169–80. https://doi.org/10.1016/j.trecan.2017.01.005.CrossRefPubMedPubMedCentral

29.

Csibi A, Fendt SM, Li C, Poulogiannis G, Choo AY, Chapski DJ, et al. The mTORC1 pathway stimulates glutamine metabolism and cell proliferation by repressing SIRT4. Cell. 2013;153(4):840–54. https://doi.org/10.1016/j.cell.2013.04.023.CrossRefPubMedPubMedCentral

30.

Kung HN, Marks JR, Chi JT. Glutamine synthetase is a genetic determinant of cell type-specific glutamine independence in breast epithelia. PLoS Genet. 2011;7(8):e1002229. https://doi.org/10.1371/journal.pgen.1002229.CrossRefPubMedPubMedCentral

31.

Lien EC, Lyssiotis CA, Cantley LC. Metabolic reprogramming by the PI3K-Akt-mTOR pathway in cancer. Recent Results Cancer Res Fortschritte der Krebsforschung Progres dans les recherches sur le cancer. 2016;207:39–72. https://doi.org/10.1007/978-3-319-42118-6_3.CrossRefPubMed

32.

Li T, Le A. Glutamine metabolism in cancer. Adv Exp Med Biol. 2018;1063:13–32. https://doi.org/10.1007/978-3-319-77736-8_2.CrossRefPubMed

33.

Škara L, Huđek Turković A, Pezelj I, Vrtarić A, Sinčić N, Krušlin B, et al. Prostate cancer-focus on cholesterol. Cancers. 2021. https://doi.org/10.3390/cancers13184696.CrossRefPubMedPubMedCentral

34.

Chen A, Xu M, Chen J, Chen T, Wang Q, Zhang R, et al. Plasma-based metabolomics profiling of high-risk human papillomavirus and their emerging roles in the progression of cervical cancer. Biomed Res Int. 2022;2022:6207701. https://doi.org/10.1155/2022/6207701.CrossRefPubMedPubMedCentral

35.

Mahon MM, deSouza NM, Dina R, Soutter WP, McIndoe GA, Williams AD, et al. Preinvasive and invasive cervical cancer: an ex vivo proton magic angle spinning magnetic resonance spectroscopy study. NMR Biomed. 2004;17(3):144–53. https://doi.org/10.1002/nbm.869.CrossRefPubMed

36.

Ying-ying Z, Yu-yan G, Hui L, Hong-tao Z, Xiao-feng G. Research progress of abnormal lipid metabolism in malignant tumor. Prog Modern Biomed. 2015;15(09):1798–800. https://doi.org/10.13241/j.cnki.pmb.2015.09.052.CrossRef

37.

Suarez RK. Energy and metabolism. Compr Physiol. 2012;2(4):2527–40. https://doi.org/10.1002/cphy.c110009.CrossRefPubMed

38.

Alvarez CL, Troncoso MF, Espelt MV. Extracellular ATP and adenosine in tumor microenvironment: roles in epithelial-mesenchymal transition, cell migration, and invasion. J Cell Physiol. 2022;237(1):389–400. https://doi.org/10.1002/jcp.30580.CrossRefPubMed

39.

Zhang Z, Chen F, Li S, Guo H, Xi H, Deng J, et al. ERG the modulates Warburg effect and tumor progression in cervical cancer. Biochem Biophys Res Commun. 2020;522(1):191–7. https://doi.org/10.1016/j.bbrc.2019.11.079.CrossRefPubMed

40.

Maldonado PA, Negrini LA, Ethur Jda S, Oliveira L, Corrêa Mde C, Becker LV, et al. Nucleotide degrading enzymes in platelets from uterine cervical neoplasia patients treated with conization or radiotherapy. Biomed Pharmacother. 2010;64(7):499–504. https://doi.org/10.1016/j.biopha.2010.02.007.CrossRefPubMed

41.

Jelic MD, Mandic AD, Maricic SM, Srdjenovic BU. Oxidative stress and its role in cancer. J Cancer Res Ther. 2021;17(1):22–8. https://doi.org/10.4103/jcrt.JCRT_862_16.CrossRefPubMed

42.

Reyna-Jeldes M, Díaz-Muñoz M, Madariaga JA, Coddou C, Vázquez-Cuevas FG. Autocrine and paracrine purinergic signaling in the most lethal types of cancer. Purinergic Signalling. 2021;17(3):345–70. https://doi.org/10.1007/s11302-021-09785-8.CrossRefPubMedPubMedCentral

43.

Woo HM, Kim KM, Choi MH, Jung BH, Lee J, Kong G, et al. Mass spectrometry based metabolomic approaches in urinary biomarker study of women’s cancers. Clinica Chimica Acta Int J Clin Chem. 2009;400(12):63–9. https://doi.org/10.1016/j.cca.2008.10.014.CrossRef

44.

Basu J, Mikhail MS, Ahn CW, Furguiele J, Ho GY, Burk RD, et al. Plasma uric acid levels in women with cervical intraepithelial neoplasia. Nutr Cancer. 2005;51(1):25–31. https://doi.org/10.1207/s15327914nc5101_4.CrossRefPubMed

45.

Gkotsos G, Virgiliou C, Lagoudaki I, Sardeli C, Raikos N, Theodoridis G, et al. The role of sarcosine, uracil, and Kynurenic acid metabolism in urine for diagnosis and progression monitoring of prostate Cancer. Metabolites. 2017. https://doi.org/10.3390/metabo7010009.CrossRefPubMedPubMedCentral

46.

Ogihara T, Kim HS, Hirano K, Imanishi M, Ogihara H, Tamai H, et al. Oxidation products of uric acid and ascorbic acid in preterm infants with chronic lung disease. Biol Neonate. 1998;73(1):24–33. https://doi.org/10.1159/000013956.CrossRefPubMed

47.

Jin L, Xue R, Xiang-Liang L, Ze-Feng L. A metabonomics study of cervical cancer by ultra performance liquid chromatography coupled with quadrupole orbitrap tandem mass spectrometry. Chinese J Anal Chem. 2018;46(01):67–73. https://doi.org/10.11895/j.issn.0253-3820.171412.CrossRef

48.

Guo Y, Xu LS, Zhang D, Liao YP, Wang HP, Lan ZH, et al. Betaine effects on morphology, proliferation, and p53-induced apoptosis of HeLa cervical carcinoma cells in vitro. Asian Pacific J Cancer Prevent APJCP. 2015;16(8):3195–201. https://doi.org/10.7314/apjcp.2015.16.8.3195.CrossRef

49.

Schicho R, Shaykhutdinov R, Ngo J, Nazyrova A, Schneider C, Panaccione R, et al. Quantitative metabolomic profiling of serum, plasma, and urine by (1)H NMR spectroscopy discriminates between patients with inflammatory bowel disease and healthy individuals. J Proteome Res. 2012;11(6):3344–57. https://doi.org/10.1021/pr300139q.CrossRefPubMedPubMedCentral

50.

Roci I, Watrous JD, Lagerborg KA, Jain M, Nilsson R. Mapping choline metabolites in normal and transformed cells. Metabol Off J Metabolomic Soc. 2020;16(12):125. https://doi.org/10.1007/s11306-020-01749-0.CrossRef

51.

Sonkar K, Ayyappan V, Tressler CM, Adelaja O, Cai R, Cheng M, et al. Focus on the glycerophosphocholine pathway in choline phospholipid metabolism of cancer. NMR Biomed. 2019;32(10):e4112. https://doi.org/10.1002/nbm.4112.CrossRefPubMedPubMedCentral

52.

Glunde K, Bhujwalla ZM, Ronen SM. Choline metabolism in malignant transformation. Nat Rev Cancer. 2011;11(12):835–48. https://doi.org/10.1038/nrc3162.CrossRefPubMedPubMedCentral

53.

Jiménez-Castillo V, Illescas-Barbosa D, Zenteno E, Ávila-Curiel BX, Castañeda-Patlán MC, Robles-Flores M, et al. Increased O-GlcNAcylation promotes IGF-1 receptor/PhosphatidyI Inositol-3 kinase/Akt pathway in cervical cancer cells. Sci Rep. 2022;12(1):4464. https://doi.org/10.1038/s41598-022-08445-0.CrossRefPubMedPubMedCentral

54.

Lei L, Mou Q. Exosomal taurine up-regulated 1 promotes angiogenesis and endothelial cell proliferation in cervical cancer. Cancer Biol Ther. 2020;21(8):717–25. https://doi.org/10.1080/15384047.2020.1764318.CrossRefPubMedPubMedCentral

55.

Chen C, Xia S, He J, Lu G, Xie Z, Han H. Roles of taurine in cognitive function of physiology, pathologies and toxication. Life Sci. 2019;231:116584. https://doi.org/10.1016/j.lfs.2019.116584.CrossRefPubMed

56.

Wen C, Li F, Zhang L, Duan Y, Guo Q, Wang W, et al. Taurine is involved in energy metabolism in muscles, adipose tissue, and the liver. Mol Nutr Food Res. 2019;63(2):e1800536. https://doi.org/10.1002/mnfr.201800536.CrossRefPubMed

57.

Zhang X, Lu H, Wang Y, Liu C, Zhu W, Zheng S, et al. Taurine induces the apoptosis of breast cancer cells by regulating apoptosis-related proteins of mitochondria. Int J Mol Med. 2015;35(1):218–26. https://doi.org/10.3892/ijmm.2014.2002.CrossRefPubMed

58.

Rodrigues D, Jerónimo C, Henrique R, Belo L, de Lourdes BM, de Pinho PG, et al. Biomarkers in bladder cancer: a metabolomic approach using in vitro and ex vivo model systems. Int J Cancer. 2016;139(2):256–68. https://doi.org/10.1002/ijc.30016.CrossRefPubMed

59.

Zhang X, Tu S, Wang Y, Xu B, Wan F. Mechanism of taurine-induced apoptosis in human colon cancer cells. Acta Biochim Biophys Sin. 2014;46(4):261–72. https://doi.org/10.1093/abbs/gmu004.CrossRefPubMed

60.

García-Raso A, Terrón A, Ortega-Castro J, Barceló-Oliver M, Lorenzo J, Rodríguez-Calado S, et al. Iridium(III) coordination of N(6) modified adenine derivatives with aminoacid chains. J Inorg Biochem. 2020;205:111000. https://doi.org/10.1016/j.jinorgbio.2020.111000.CrossRefPubMed

61.

Boroughs LK, DeBerardinis RJ. Metabolic pathways promoting cancer cell survival and growth. Nat Cell Biol. 2015;17(4):351–9. https://doi.org/10.1038/ncb3124.CrossRefPubMedPubMedCentral

62.

Dang CV. Glutaminolysis: supplying carbon or nitrogen or both for cancer cells? Cell Cycle. 2010;9(19):3884–6. https://doi.org/10.4161/cc.9.19.13302.CrossRefPubMed

63.

Zhang J, Pavlova NN, Thompson CB. Cancer cell metabolism: the essential role of the nonessential amino acid, glutamine. EMBO J. 2017;36(10):1302–15. https://doi.org/10.15252/embj.201696151.CrossRefPubMedPubMedCentral

64.

Ning Y, Wang C, Liu X, Du Y, Liu S, Liu K, et al. CK2-mediated CCDC106 phosphorylation is required for p53 degradation in cancer progression. J Exp Clin Cancer Res CR. 2019;38(1):131. https://doi.org/10.1186/s13046-019-1137-8.CrossRefPubMed

65.

Bedell SL, Goldstein LS, Goldstein AR, Goldstein AT. Cervical cancer screening: past, present, and future. Sexual Med Rev. 2020;8(1):28–37. https://doi.org/10.1016/j.sxmr.2019.09.005.CrossRef

66.

Melnikow J, Henderson JT, Burda BU, Senger CA, Durbin S, Weyrich MS. Screening for cervical cancer with high-risk human papillomavirus testing: updated evidence report and systematic review for the US preventive services task force. JAMA. 2018;320(7):687–705. https://doi.org/10.1001/jama.2018.10400.CrossRefPubMed

67.

Paraskevaidi M, Cameron SJS, Whelan E, Bowden S, Tzafetas M, Mitra A, et al. Laser-assisted rapid evaporative ionisation mass spectrometry (LA-REIMS) as a metabolomics platform in cervical cancer screening. EBioMedicine. 2020;60:103017. https://doi.org/10.1016/j.ebiom.2020.103017.CrossRefPubMedPubMedCentral

68.

Tavakoli F, Khatami SS, Momeni F, Azadbakht J, Ghasemi F. Cervical cancer diagnosis: insights into biochemical biomarkers and imaging techniques. Comb Chem High Throughput Screening. 2021;24(5):605–23. https://doi.org/10.2174/1386207323666200901101955.CrossRef

69.

Gadducci A, Cosio S. Neoadjuvant chemotherapy in locally advanced cervical cancer: review of the literature and perspectives of clinical research. Anticancer Res. 2020;40(9):4819–28. https://doi.org/10.21873/anticanres.14485.CrossRefPubMed

70.

Qiu F, Zhao X. Study on the sensitivity of primary tumor cells of patients with cervical cancer to chemotherapeutic combinations. J BUON Off J Balkan Union Oncol. 2018;23(1):117–23.

71.

Hou Y, Yin M, Sun F, Zhang T, Zhou X, Li H, et al. A metabolomics approach for predicting the response to neoadjuvant chemotherapy in cervical cancer patients. Mol BioSyst. 2014;10(8):2126–33. https://doi.org/10.1039/c4mb00054d.CrossRefPubMed

72.

Chai Y, Wang J, Wang T, Yang Y, Su J, Shi F, et al. Application of 1H NMR spectroscopy-based metabonomics to feces of cervical cancer patients with radiation-induced acute intestinal symptoms. Radiother Oncol J Eur Soc Therapeutic Radiol Oncol. 2015;117(2):294–301. https://doi.org/10.1016/j.radonc.2015.07.037.CrossRef

73.

Reis Ferreira M, Andreyev HJN, Mohammed K, Truelove L, Gowan SM, Li J, et al. Microbiota- and radiotherapy-induced gastrointestinal side-effects (MARS) study: a large pilot study of the microbiome in acute and late-radiation enteropathy. Clin Cancer Res Off J Am Associat Cancer Res. 2019;25(21):6487–500. https://doi.org/10.1158/1078-0432.Ccr-19-0960.CrossRef

74.

Doherty B, Lawlor D, Gillet JP, Gottesman M, O’Leary JJ, Stordal B. Collateral sensitivity to cisplatin in KB-8-5-11 drug-resistant cancer cells. Anticancer Res. 2014;34(1):503–7.PubMed

75.

Liu J, Wang M, Zhang X, Wang Q, Qi M, Hu J, et al. CIP2A is associated with multidrug resistance in cervical adenocarcinoma by a P-glycoprotein pathway. Tumour Boil J Int Soc Oncodevelop Biol Med. 2016;37(2):2673–82. https://doi.org/10.1007/s13277-015-4032-8.CrossRef

76.

Kim DH, Allwood JW, Moore RE, Marsden-Edwards E, Dunn WB, Xu Y, et al. A metabolomics investigation into the effects of HIV protease inhibitors on HPV16 E6 expressing cervical carcinoma cells. Mol BioSyst. 2014;10(3):398–411. https://doi.org/10.1039/c3mb70423h.CrossRefPubMed

77.

Huang W, He T, Chai C, Yang Y, Zheng Y, Zhou P, et al. Triptolide inhibits the proliferation of prostate cancer cells and down-regulates SUMO-specific protease 1 expression. PLoS ONE. 2012;7(5):e37693. https://doi.org/10.1371/journal.pone.0037693.CrossRefPubMedPubMedCentral

78.

Hu Y, Qi Y, Liu H, Fan G, Chai Y. Effects of celastrol on human cervical cancer cells as revealed by ion-trap gas chromatography-mass spectrometry based metabolic profiling. Biochem Biophys Acta. 2013;1830(3):2779–89. https://doi.org/10.1016/j.bbagen.2012.10.024.CrossRefPubMed

79.

Tyszka-Czochara M, Bukowska-Strakova K, Kocemba-Pilarczyk KA, Majka M. Caffeic acid targets AMPK signaling and regulates tricarboxylic acid cycle anaplerosis while metformin downregulates HIF-1α-induced glycolytic enzymes in human cervical squamous cell carcinoma lines. Nutrients. 2018. https://doi.org/10.3390/nu10070841.CrossRefPubMedPubMedCentral

80.

Gu H, Gowda GA, Raftery D. Metabolic profiling: are we en route to better diagnostic tests for cancer? Future Oncol. 2012;8(10):1207–10. https://doi.org/10.2217/fon.12.113.CrossRefPubMed

81.

Granot-Hershkovitz E, He S, Bressler J, Yu B, Tarraf W, Rebholz CM, et al. Plasma metabolites associated with cognitive function across race/ethnicities affirming the importance of healthy nutrition. Alzheimer’s Dementia. 2023;19(4):1331–42. https://doi.org/10.1002/alz.12786.CrossRefPubMed

Title: Research progress of metabolomics in cervical cancer
Authors: Yuhan Jia
Kun Zou
Lijuan Zou
Publication date: 01-12-2023
Publisher: BioMed Central
Keywords: Cervical Cancer
Cervical Cancer
Published in: European Journal of Medical Research / Issue 1/2023
Electronic ISSN: 2047-783X
DOI: https://doi.org/10.1186/s40001-023-01490-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Research progress of metabolomics in cervical cancer

Abstract

Introduction

Objectives

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Introduction

Objectives

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2023

A risk score to predict 30-day hospital readmission rate in cirrhotic patients with spontaneous bacterial peritonitis

Screening of hub inflammatory bowel disease biomarkers and identification of immune-related functions based on basement membrane genes

Circulating miRNAs signature on breast cancer: the MCC-Spain project

Minimal-access video-assisted retroperitoneal and/or transperitoneal debridement (VARTD) in the management of infected walled-off pancreatic necrosis with deep extension: initial experience from a prospective single-arm study

Complement C3 mediates podocyte injury through TLR4/NFΚB-P65 signaling during ischemia–reperfusion acute kidney injury and post-injury fibrosis

Standard versus innovative robotic balance assessment for people with multiple sclerosis: a correlational study